Description

Doxtored (Docetaxel) Concentrated Solution for Infusions 20 mg/ml. 1ml. (20 mg.) Vial №1

Ingredients:

Each vial contains 20 mg of docetaxel in a concentrated solution for infusion.

Dosage:

The recommended dosage of Doxtored is determined by the patient’s body surface area and the specific condition being treated. It is administered intravenously under the supervision of a healthcare professional.

Indications:

Doxtored is indicated for the treatment of various types of cancer, including breast cancer, non-small cell lung cancer, prostate cancer, and others.

Contraindications:

Doxtored is contraindicated in patients with a history of severe hypersensitivity reactions to docetaxel or other ingredients in the formulation.

Directions:

Doxtored should only be administered by healthcare professionals experienced in the use of cytotoxic agents. The infusion should be given over a specific period as directed.

Scientific Evidence:

Docetaxel, the active ingredient in Doxtored, works by disrupting the microtubular network in cells, leading to cell cycle arrest and ultimately cell death. This mechanism of action has been extensively studied and proven effective in the treatment of various cancers.

Clinical trials have demonstrated the efficacy of docetaxel in improving overall survival and progression-free survival in patients with advanced cancer. Research published in the Journal of Clinical Oncology has shown that docetaxel-based regimens are superior to other chemotherapy options in certain cancer types.

Additional Information:

• Storage: Store Doxtored vials in a cool, dry place away from light.
• Side Effects: Common side effects may include neutropenia, fatigue, and fluid retention.
• Precautions: Patients should be monitored closely for signs of infection during treatment with Doxtored.